TrialJournal of neurology, neurosurgery, and psychiatry2019

Oral levosimendan in amyotrophic lateral sclerosis: a phase II multicentre, randomised, double-blind, placebo-controlled trial.

Ammar Al-Chalabi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.